Aggressive Lymphomas the Focus of New York Oncology Hematology’s 10th Annual Spring to Life Conference


CME Credits Available for Medical Professionals Complimentary, In-Person Event May 5th & 6th in Saratoga Springs, NY

Aggressive lymphomas are the focus of New York Oncology Hematology’s 10th Annual Spring to Life Conference. The event is open to medical professionals for CME credit and includes a session for cancer survivors and caregivers. This year’s Spring to Life conference will be held May 5-6, 2023, at The Saratoga Hilton in Saratoga Springs, NY.

“We are seeing exciting new and emerging novel therapies that are truly impacting the lives of patients with aggressive lymphomas, building on past successes,” explains Ira Zackon, MD, of New York Oncology Hematology (NYOH) and conference co-chair. “Bringing together top clinicians and researchers from our region, we can explain how these treatments are working – but how they work together.”

A full schedule, list of presenters, and online registration are available at: spring2liferegistration.org

Aggressive lymphomas refer to those that grow and advance more quickly. Hematology experts from NYOH, Dana Farber Cancer Institute, Memorial Sloan Kettering, Weill Cornell, and the University of Rochester will share essential developments in the biological pathways, diagnosis, current guidelines, and the existing and emerging therapies for this type of blood cancer.

“From targeted therapies to multi-drug regimens, we can now offer our patients a growing menu of treatment options to manage the disease – including relapses,” explains Mihir Raval, MD, conference co-chair. “We look forward to bringing practitioners together, in person, for our 10th conference and sharing these important advancements.”

The conference is complimentary for medical oncologists, hematologists, pathologists, oncology nurses, advanced practice providers, family practitioners, primary care practitioners, allied health professionals, and all other healthcare professionals caring for patients with Lymphoma. A maximum of 8.0 AMA PRA Category 1 Credits are available to attendees. Nurses and other healthcare professionals receive a Certificate of Participation.

The Spring to Life Conference is presented in collaboration with the Medical Society of the State of New York, the Leukemia Lymphoma Society, the American Cancer Society, and myMedEd, Inc.

This year’s conference also includes a special afternoon session, complimentary for cancer patients, survivors, family members, and caregivers. On May 6, 2023, from 3:30 p.m. – 5:30 p.m., “Enduring Big Emotions” will explore hands-on techniques for managing the mental impact of cancer treatment. The session will include writing, gratitude, and commitment therapies and will be led by social workers and therapists.

About Spring to Life

Created by NYOH in 2013, Spring to Life™ is an annual conference for medical professionals focusing on emerging treatments in oncology and hematology. As part of its ongoing community commitment as the region’s largest cancer care provider, NYOH provides a complimentary program for patients and survivors diagnosed with cancer, their families, companions, and caregivers. Healthcare professionals are welcome and encouraged to participate in the afternoon of patient-centered sessions.

About New York Oncology Hematology

New York Oncology Hematology (NYOH) is the leading provider of community-based cancer care and blood disorder services. With six convenient locations in Albany, Amsterdam, Clifton Park, Hudson, and Troy, our team of more than 50 providers and 300 cancer care specialists see more than 100,000 cancer visits annually. Our affiliation with The US Oncology Network, one of the nation’s leading cancer treatment and research networks, puts NYOH on the front lines of the latest research breakthroughs, treatments, and technologies.

Contact:

Nicole Falco

myMedEd, Inc.

info@mymededco.com

Partner websites:

https://newyorkoncology.com

https://mymededco.com

https://cme.mssny.org/accreditation

https://www.lls.org

https://www.cancer.org

Share article on social media or email:

Leave a Reply